Personalized Medicine: Paradigm of the Future for Cancer Treatment
Personalized or targeted medicine is the paradigm of the future: treatment options customized for individual patients.
Cancer Drug Nivolumab Receives Regulatory Approval in Japan
A recent article from FierceBiotech announced that theAnti-PD-1 cancer drug nivolumab, a fully human antibody, received regulatory approval in Japan.
21st Century Cures Hearing In Washington D.C.
Marshall Summar, MD to testify on behalf of NORD at 21st Century Cures Hearing in Washington, D. C. on Friday, July 11 at 9 AM ET.
GIST Awareness Day Highlighted in New Press Release
Coverage of GIST Awareness Day continues with this press release that calls attention to our awareness campaign and our support for the global GIST community.
New tool assesses the financial pain of cancer treatment
As the cost of cancer treatment rises, so does the anxiety level of those diagnosed. The University of Chicago has developed a tool to assess the financial pain of cancer treatment. In the July issue of [...]
Cancer Treatment – The importance of patient enrollment in clinical trials
The future of cancer treatment relies on patient enrollment in clinical trials. In a recent Chicago Tribune article, a patient story is highlighted to illustrate the important role clinical trials play in cancer treatment, not only in [...]
Cancer Treatment – The Emotional and Economic Costs
There are multiple costs associated with cancer treatment. The emotional cost of cancer is obvious: fear and anxiety become constant companions. The economic cost is less apparent initially, as the patient and their support team [...]
The Life Raft Group Celebrates 12 years as a non-profit
It’s hard to believe that 12 years have passed since the Life Raft Group officially became a non-profit organization. We have accomplished so much during that time, and look forward to accomplishing more, keeping in [...]
The Future of Research for Rare Cancers
Two recent articles highlight the need to focus attention on cancers that have previously been less widely acknowledged by both funding and attention by the general public. The first article from the Genetic Engineering [...]
Affect Change From The Top: A GIST Advocacy Primer
In preparation for July 13th's GIST Awareness Day we have invited top advocates to share their best strategies on how to campaign for change and raise awareness about GIST.